|
Cardiovascular Pharmacology
Citations 61-70 of 1154 total displayed.
|
Past content
(since Jan 1999):
|
- Heart Failure
Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure: The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) Trial
- Barry M. Massie, Joseph F. Collins, Susan E. Ammon, Paul W. Armstrong, John G.F. Cleland, Michael Ezekowitz, Syed M. Jafri, William F. Krol, Christopher M. O'Connor, Kevin A. Schulman, Koon Teo, Stuart R. Warren for the WATCH Trial Investigators
Circulation 2009;119:1616-1624; published online before print as doi:10.1161/CIRCULATIONAHA.108.801753
[Abstract]
[Full text]
- Correspondence
Letter by Scheuer Regarding Article, "Trimetazidine, a Metabolic Modulator, Has Cardiac and Extracardiac Benefits in Idiopathic Dilated Cardiomyopathy"
- James Scheuer
Circulation 2009;119:e371, doi:10.1161/CIRCULATIONAHA.108.831875
[Full text]
- Correspondence
Response to Letter Regarding Article, "Trimetazidine, a Metabolic Modulator, Has Cardiac and Extracardiac Benefits in Idiopathic Dilated Cardiomyopathy"
- Helena Tuunanen, Juhani Knuuti, and Lionel H. Opie
Circulation 2009;119:e372, doi:10.1161/CIRCULATIONAHA.108.835595
[Full text]
- Articles
Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure. The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) Trial
- Barry M. Massie, Joseph F. Collins, Susan E. Ammon, Paul W. Armstrong, John G.F. Cleland, Michael Ezekowitz, Syed M. Jafri, William F. Krol, Christopher M. O'Connor, Kevin A. Schulman, Koon Teo, Stuart R. Warren for the WATCH Trial Investigators
Circulation published March 16, 2009, doi:10.1161/CIRCULATIONAHA.108.801753
[Abstract]
- Cardiology Patient Pages
A Patient’s Guide to Taking Coumadin/Warfarin
- Karen Fiumara and Samuel Z. Goldhaber
Circulation 2009;119:e220-222e, doi:10.1161/CIRCULATIONAHA.108.803957
[Full text]
- Molecular Cardiology
AMP-Activated Protein Kinase Deficiency Enhances Myocardial Ischemia/Reperfusion Injury but Has Minimal Effect on the Antioxidant/Antinitrative Protection of Adiponectin
- Yajing Wang, Erhe Gao, Ling Tao, Wayne Bond Lau, Yuexin Yuan, Barry J. Goldstein, Bernard L. Lopez, Theodore A. Christopher, Rong Tian, Walter Koch, and Xin-Liang Ma
Circulation 2009;119:835-844; published online before print as doi:10.1161/CIRCULATIONAHA.108.815043
[Abstract]
[Full text]
- Heart Failure
Long-Term Trends in First Hospitalization for Heart Failure and Subsequent Survival Between 1986 and 2003: A Population Study of 5.1 Million People
- Pardeep S. Jhund, Kate MacIntyre, Colin R. Simpson, James D. Lewsey, Simon Stewart, Adam Redpath, James W.T. Chalmers, Simon Capewell, and John J.V. McMurray
Circulation 2009;119:515-523; published online before print as doi:10.1161/CIRCULATIONAHA.108.812172
[Abstract]
[Full text]
- Vascular Medicine
Altered Bone Morphogenetic Protein and Transforming Growth Factor-β Signaling in Rat Models of Pulmonary Hypertension: Potential for Activin Receptor-Like Kinase-5 Inhibition in Prevention and Progression of Disease
- Lu Long, Alexi Crosby, Xudong Yang, Mark Southwood, Paul D. Upton, Dae-Kee Kim, and Nicholas W. Morrell
Circulation 2009;119:566-576; published online before print as doi:10.1161/CIRCULATIONAHA.108.821504
[Abstract]
[Full text]
- Statistical Primer for Cardiovascular Research
Optimizing Trial Design: Sequential, Adaptive, and Enrichment Strategies
- Cyrus Mehta, Ping Gao, Deepak L. Bhatt, Robert A. Harrington, Simona Skerjanec, and James H. Ware
Circulation 2009;119:597-605, doi:10.1161/CIRCULATIONAHA.108.809707
[Full text]
- Articles
AMP-Activated Protein Kinase Deficiency Enhances Myocardial Ischemia/Reperfusion Injury but Has Minimal Effect on the Antioxidant/Antinitrative Protection of Adiponectin
- Yajing Wang, Erhe Gao, Ling Tao, Wayne Bond Lau, Yuexin Yuan, Barry J. Goldstein, Bernard L. Lopez, Theodore A. Christopher, Rong Tian, Walter Koch, and Xin-Liang Ma
Circulation published February 2, 2009, doi:10.1161/CIRCULATIONAHA.108.815043
[Abstract]
|
|
